REDHILL BIOPHARMA LTD. (RDHL) Gross margin 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) gross margin by fiscal year — reported gross profit divided by reported revenue.
60.3%FY2024 · since FY2015: 100.0% → 60.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 60.3% | +13.3 pp |
| FY2023 | 47.0% | +1.0 pp |
| FY2022 | 46.1% | +3.7 pp |
| FY2021 | 42.4% | -0.3 pp |
| FY2020 | 42.7% | -21.4 pp |
| FY2019 | 64.1% | -2.0 pp |
| FY2018 | 66.1% | +19.1 pp |
| FY2017 | 46.9% | -53.1 pp |
| FY2016 | 100.0% | +0.0 pp |
| FY2015 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice